Literature DB >> 31650094

Impact of Mood on Endothelial Function and Arterial Stiffness in Bipolar Disorder.

Samantha L Schmitz1, Oluchi J Abosi1,2, Jane E Persons3, Christine A Sinkey4, Jess G Fiedorowicz1,2,3,5,6,7.   

Abstract

BACKGROUND: Previous research in bipolar disorder demonstrates greater than expected vascular dysfunction later in the course of illness, proportionate to the cumulative burden of mood symptoms. However, little is known about the effect of acute mood states on vascular function. Here we examine the relation between vascular function and mood state in individuals with bipolar disorder.
METHOD: This prospective study followed 40 individuals with bipolar disorder for up to 6 months. Participants were assessed for mood state and vascular function at baseline, 2 weeks, and 6 months. Mood state was determined using clinician-administered Montgomery-Åsberg Depression Rating Scale and Young Mania Rating Scale. Vascular function was assessed by flow-mediated dilation (FMD) of the brachial artery, forearm vascular resistance (FVR), and arterial stiffness.
RESULTS: Participants had a mean age of 30.1 years and 75% were male. Primary outcome measures FMD and nitroglycerine-mediated dilation were not found to have statistically significant associations with depressive or manic symptoms. In unadjusted models, higher manic symptoms were significantly associated with increased FVR nitroprusside-mediated dilation and diastolic blood pressure. In adjusted models, higher depressive symptoms were significantly associated with increases in augmentation index adjusted for heart rate of 75 bpm, and higher manic symptoms remained associated with increases in diastolic blood pressure.
CONCLUSION: FMD may have limited sensitivity as a biomarker for measuring short-term effects of mood state. Longer-term prospective studies are needed to clarify the temporal relation between chronic mood symptoms and vascular function in bipolar disorder.

Entities:  

Keywords:  Bipolar disorder; arterial stiffness; cardiovascular risk; endothelial dysfunction

Year:  2019        PMID: 31650094      PMCID: PMC6812514          DOI: 10.4103/hm.hm_20_19

Source DB:  PubMed          Journal:  Heart Mind (Mumbai)        ISSN: 2468-6476


  44 in total

Review 1.  Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry.

Authors:  Ralitza Gueorguieva; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2004-03

2.  Abnormal brachial artery flow-mediated vasodilation in young adults with major depression.

Authors:  S Rajagopalan; R Brook; M Rubenfire; E Pitt; E Young; B Pitt
Journal:  Am J Cardiol       Date:  2001-07-15       Impact factor: 2.778

3.  Cardiac vagal control in depression: a critical analysis.

Authors:  Jonathan Rottenberg
Journal:  Biol Psychol       Date:  2006-10-12       Impact factor: 3.251

4.  Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder.

Authors:  Jess G Fiedorowicz; David A Solomon; Jean Endicott; Andrew C Leon; Chunshan Li; John P Rice; William H Coryell
Journal:  Psychosom Med       Date:  2009-06-26       Impact factor: 4.312

5.  Detecting alcoholism. The CAGE questionnaire.

Authors:  J A Ewing
Journal:  JAMA       Date:  1984-10-12       Impact factor: 56.272

6.  The effect of treatment response on endothelial function and arterial stiffness in depression. A prospective study.

Authors:  Nikolaos Kokras; Efthymia Papadopoulou; Georgios Georgiopoulos; Christina Dalla; Ioannis Petropoulos; Christos Kontogiannis; Ageliki Laina; Dimitrios Bampatsias; Konstantinos Stellos; Anastasios V Kouzoupis; Kimon Stamatelopoulos
Journal:  J Affect Disord       Date:  2019-04-09       Impact factor: 4.839

Review 7.  Mania and mortality: why the excess cardiovascular risk in bipolar disorder?

Authors:  Dylan P Murray; Miriam Weiner; Maithri Prabhakar; Jess G Fiedorowicz
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

8.  Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers.

Authors:  Sashi Guthikonda; Christine Sinkey; Therese Barenz; William G Haynes
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

9.  Reversal of increased arterial stiffness in severely depressed women after 6-week antidepressant treatment.

Authors:  Panagiotis Oulis; Anastasios Kouzoupis; Katerina Kyrkou; Vasilios G Masdrakis; George Georgiopoulos; Evangelos Karapoulios; Stellios Georgiou; Nikolaos A Karakatsanis; Maria Lykka; George N Papadimitriou; Christos Papamichael; Kimon Stamatelopoulos
Journal:  J Affect Disord       Date:  2009-09-03       Impact factor: 4.839

10.  Association of anxiety with resistance vessel dysfunction in human atherosclerosis.

Authors:  Ashley N Stillman; David J Moser; Jess Fiedorowicz; Heather M Robinson; William G Haynes
Journal:  Psychosom Med       Date:  2013-06-20       Impact factor: 4.312

View more
  4 in total

Review 1.  Role of Neuroimmune Interactions in COVID-19-related Cardiovascular Damage.

Authors:  Xing Chen; Wei-Hua Qiao; Hong Cao; Jia-Wei Shi; Xin-Ling Du; Nian-Guo Dong
Journal:  Curr Med Sci       Date:  2022-06-08

Review 2.  Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments.

Authors:  Gerwyn Morris; Basant K Puri; Lisa Olive; Andre Carvalho; Michael Berk; Ken Walder; Lise Tuset Gustad; Michael Maes
Journal:  BMC Med       Date:  2020-10-19       Impact factor: 8.775

Review 3.  Blood-brain barrier dysfunction in bipolar disorder: Molecular mechanisms and clinical implications.

Authors:  Ning O Zhao; Natasha Topolski; Massimo Tusconi; Erika M Salarda; Christopher W Busby; Camila N N C Lima; Anilkumar Pillai; Joao Quevedo; Tatiana Barichello; Gabriel R Fries
Journal:  Brain Behav Immun Health       Date:  2022-03-05

Review 4.  Novel Insight into Neuroimmune Regulatory Mechanisms and Biomarkers Linking Major Depression and Vascular Diseases: The Dilemma Continues.

Authors:  Ingrid Tonhajzerova; Nikola Sekaninova; Lucia Bona Olexova; Zuzana Visnovcova
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.